To evaluate whether epigenetic gene silencing occurs in renal cancer tissue, we analyzed the relationship between promoter methylation and expression of VEGF, FLT1, and KDR in normal vs. cancer tissues collected from eight renal cancer patients (Fig. 3). This evidence concerns the gene FLT1 and renal carcinoma.